Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort Study

Background: Coagulation factor XII (FXII) is involved in pathological thrombus formation and is a suggested target of anticoagulants. It is unclear whether FXII levels are correlated with cardiovascular risk factors and whether they are associated with myocardial infarction or ischemic or hemorrhagi...

Full description

Bibliographic Details
Published in:Cerebrovascular Diseases Extra
Main Authors: Kristina Johansson, Jan-Håkan Jansson, Lars Johansson, Ingemar Bylesjö, Torbjörn K. Nilsson, Mats Eliasson, Stefan Söderberg, Marcus Lind
Format: Article in Journal/Newspaper
Language:English
Published: Karger Publishers 2017
Subjects:
Online Access:https://doi.org/10.1159/000468994
https://doaj.org/article/91f13261b8ab42459d9c855572198187
id ftdoajarticles:oai:doaj.org/article:91f13261b8ab42459d9c855572198187
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:91f13261b8ab42459d9c855572198187 2023-05-15T17:45:00+02:00 Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort Study Kristina Johansson Jan-Håkan Jansson Lars Johansson Ingemar Bylesjö Torbjörn K. Nilsson Mats Eliasson Stefan Söderberg Marcus Lind 2017-04-01T00:00:00Z https://doi.org/10.1159/000468994 https://doaj.org/article/91f13261b8ab42459d9c855572198187 EN eng Karger Publishers http://www.karger.com/Article/FullText/468994 https://doaj.org/toc/1664-5456 1664-5456 doi:10.1159/000468994 https://doaj.org/article/91f13261b8ab42459d9c855572198187 Cerebrovascular Diseases Extra, Vol 7, Iss 1, Pp 84-94 (2017) Coagulation Biomarkers Intracranial hemorrhage Cohort study Cardiovascular disease Diseases of the circulatory (Cardiovascular) system RC666-701 article 2017 ftdoajarticles https://doi.org/10.1159/000468994 2022-12-31T05:28:11Z Background: Coagulation factor XII (FXII) is involved in pathological thrombus formation and is a suggested target of anticoagulants. It is unclear whether FXII levels are correlated with cardiovascular risk factors and whether they are associated with myocardial infarction or ischemic or hemorrhagic stroke. The aim of this study was to investigate the correlation between FXII and cardiovascular risk factors in the general population. We also aimed to study the associations between FXII levels and future myocardial infarction and ischemic and hemorrhagic stroke. Methods: This prospective cohort study measured FXII levels in 1,852 randomly selected participants in a health survey performed in northern Sweden in 1994. Participants were followed until myocardial infarction, stroke, death, or until December 31, 2011. Results: During the median follow-up of 17.9 years, 165 individuals were diagnosed with myocardial infarction, 108 with ischemic stroke, and 30 with hemorrhagic stroke. There were weak correlations between FXII and body mass index, cholesterol, and hypertension. There was no association between FXII and myocardial infarction or ischemic stroke, neither in univariable Cox regression analysis nor after adjustment for age, sex, smoking, body mass index, cholesterol, hypertension, and diabetes. In univariable Cox regression analysis, the hazard ratio for the association between FXII levels and hemorrhagic stroke was 1.42 per SD (95% confidence interval: 0.99–2.05). In the multivariable model, higher levels of FXII were associated with increased risk of hemorrhagic stroke (hazard ratio 1.51 per SD; 95% confidence interval: 1.03–2.21). Conclusion: We found an independent association between FXII levels and the risk of hemorrhagic stroke, but not between FXII levels and ischemic stroke or myocardial infarction. Article in Journal/Newspaper Northern Sweden Directory of Open Access Journals: DOAJ Articles Cerebrovascular Diseases Extra 7 1 84 94
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic Coagulation
Biomarkers
Intracranial hemorrhage
Cohort study
Cardiovascular disease
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle Coagulation
Biomarkers
Intracranial hemorrhage
Cohort study
Cardiovascular disease
Diseases of the circulatory (Cardiovascular) system
RC666-701
Kristina Johansson
Jan-Håkan Jansson
Lars Johansson
Ingemar Bylesjö
Torbjörn K. Nilsson
Mats Eliasson
Stefan Söderberg
Marcus Lind
Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort Study
topic_facet Coagulation
Biomarkers
Intracranial hemorrhage
Cohort study
Cardiovascular disease
Diseases of the circulatory (Cardiovascular) system
RC666-701
description Background: Coagulation factor XII (FXII) is involved in pathological thrombus formation and is a suggested target of anticoagulants. It is unclear whether FXII levels are correlated with cardiovascular risk factors and whether they are associated with myocardial infarction or ischemic or hemorrhagic stroke. The aim of this study was to investigate the correlation between FXII and cardiovascular risk factors in the general population. We also aimed to study the associations between FXII levels and future myocardial infarction and ischemic and hemorrhagic stroke. Methods: This prospective cohort study measured FXII levels in 1,852 randomly selected participants in a health survey performed in northern Sweden in 1994. Participants were followed until myocardial infarction, stroke, death, or until December 31, 2011. Results: During the median follow-up of 17.9 years, 165 individuals were diagnosed with myocardial infarction, 108 with ischemic stroke, and 30 with hemorrhagic stroke. There were weak correlations between FXII and body mass index, cholesterol, and hypertension. There was no association between FXII and myocardial infarction or ischemic stroke, neither in univariable Cox regression analysis nor after adjustment for age, sex, smoking, body mass index, cholesterol, hypertension, and diabetes. In univariable Cox regression analysis, the hazard ratio for the association between FXII levels and hemorrhagic stroke was 1.42 per SD (95% confidence interval: 0.99–2.05). In the multivariable model, higher levels of FXII were associated with increased risk of hemorrhagic stroke (hazard ratio 1.51 per SD; 95% confidence interval: 1.03–2.21). Conclusion: We found an independent association between FXII levels and the risk of hemorrhagic stroke, but not between FXII levels and ischemic stroke or myocardial infarction.
format Article in Journal/Newspaper
author Kristina Johansson
Jan-Håkan Jansson
Lars Johansson
Ingemar Bylesjö
Torbjörn K. Nilsson
Mats Eliasson
Stefan Söderberg
Marcus Lind
author_facet Kristina Johansson
Jan-Håkan Jansson
Lars Johansson
Ingemar Bylesjö
Torbjörn K. Nilsson
Mats Eliasson
Stefan Söderberg
Marcus Lind
author_sort Kristina Johansson
title Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort Study
title_short Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort Study
title_full Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort Study
title_fullStr Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort Study
title_full_unstemmed Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort Study
title_sort factor xii as a risk marker for hemorrhagic stroke: a prospective cohort study
publisher Karger Publishers
publishDate 2017
url https://doi.org/10.1159/000468994
https://doaj.org/article/91f13261b8ab42459d9c855572198187
genre Northern Sweden
genre_facet Northern Sweden
op_source Cerebrovascular Diseases Extra, Vol 7, Iss 1, Pp 84-94 (2017)
op_relation http://www.karger.com/Article/FullText/468994
https://doaj.org/toc/1664-5456
1664-5456
doi:10.1159/000468994
https://doaj.org/article/91f13261b8ab42459d9c855572198187
op_doi https://doi.org/10.1159/000468994
container_title Cerebrovascular Diseases Extra
container_volume 7
container_issue 1
container_start_page 84
op_container_end_page 94
_version_ 1766147705834307584